These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 22645687)

  • 1. Outcome for patients with triple-negative breast cancer is not dependent on race/ethnicity.
    Chu QD; Henderson AE; Ampil F; Li BD
    Int J Breast Cancer; 2012; 2012():764570. PubMed ID: 22645687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of race and ethnicity on outcomes for estrogen receptor-negative breast cancers: experience of an academic center with a charity hospital.
    Chu QD; Burton G; Glass J; Smith MH; Li BD
    J Am Coll Surg; 2010 May; 210(5):585-92, 592-4. PubMed ID: 20421009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Race/Ethnicity has no effect on outcome for breast cancer patients treated at an academic center with a public hospital.
    Chu QD; Smith MH; Williams M; Panu L; Johnson LW; Shi R; Li BD; Glass J
    Cancer Epidemiol Biomarkers Prev; 2009 Aug; 18(8):2157-61. PubMed ID: 19622718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Race is not a factor in overall survival in patients with triple negative breast cancer: a retrospective review.
    Starlard-Davenport A; Glover-Collins K; Mahkoul I; Hutchins L; Westbrook K; Korourian S; Enoch K; Preston M; Jackson SN; Klimberg VS; Henry-Tillman R
    Springerplus; 2013; 2():516. PubMed ID: 25674397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does race affect outcomes in triple negative breast cancer?
    Sachdev JC; Ahmed S; Mirza MM; Farooq A; Kronish L; Jahanzeb M
    Breast Cancer (Auckl); 2010 May; 4():23-33. PubMed ID: 20697530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors associated with the triple-negative breast cancer subtype within four race/ethnicities.
    Parise CA; Caggiano V
    Breast Cancer Res Treat; 2017 May; 163(1):151-158. PubMed ID: 28213780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of type 2 diabetes mellitus on the prognosis of early stage triple-negative breast cancer in People's Republic of China.
    Ma FJ; Liu ZB; Qu L; Hao S; Liu GY; Wu J; Shao ZM
    Onco Targets Ther; 2014; 7():2147-54. PubMed ID: 25473296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are there differences in outcomes by race among women with metastatic triple-negative breast cancer?
    Oppong BA; Rolle AA; Ndumele A; Li Y; Fisher JL; Bhattacharyya O; Adeyanju T; Paskett ED
    Breast Cancer Res Treat; 2022 Nov; 196(2):399-408. PubMed ID: 36152139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiotherapy after surgery has significant survival benefits for patients with triple-negative breast cancer.
    Yao Y; Chu Y; Xu B; Hu Q; Song Q
    Cancer Med; 2019 Feb; 8(2):554-563. PubMed ID: 30632300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological features of triple-negative breast cancer in Taiwanese women.
    Yao-Lung K; Dar-Ren C; Tsai-Wang C
    Int J Clin Oncol; 2011 Oct; 16(5):500-5. PubMed ID: 21455625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triple-negative breast cancer has worse overall survival and cause-specific survival than non-triple-negative breast cancer.
    Li X; Yang J; Peng L; Sahin AA; Huo L; Ward KC; O'Regan R; Torres MA; Meisel JL
    Breast Cancer Res Treat; 2017 Jan; 161(2):279-287. PubMed ID: 27888421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is breast conservation therapy a viable option for patients with triple-receptor negative breast cancer?
    Parker CC; Ampil F; Burton G; Li BD; Chu QD
    Surgery; 2010 Aug; 148(2):386-91. PubMed ID: 20580045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poor prognosis of patients with triple-negative breast cancer can be stratified by RANK and RANKL dual expression.
    Reyes ME; Fujii T; Branstetter D; Krishnamurthy S; Masuda H; Wang X; Reuben JM; Woodward WA; Edwards BJ; Hortobagyi GN; Tripathy D; Dougall WC; Eckhardt BL; Ueno NT
    Breast Cancer Res Treat; 2017 Jul; 164(1):57-67. PubMed ID: 28417335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of tRNA-derived small noncoding RNAs as potential biomarkers for prediction of recurrence in triple-negative breast cancer.
    Feng W; Li Y; Chu J; Li J; Zhang Y; Ding X; Fu Z; Li W; Huang X; Yin Y
    Cancer Med; 2018 Oct; 7(10):5130-5144. PubMed ID: 30239174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective comparison of outcome after treatment for triple-negative and non-triple-negative breast cancer.
    Joyce DP; Murphy D; Lowery AJ; Curran C; Barry K; Malone C; McLaughlin R; Kerin MJ
    Surgeon; 2017 Oct; 15(5):272-277. PubMed ID: 28277293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opportunities for improving triple-negative breast cancer outcomes: results of a population-based study.
    Rapiti E; Pinaud K; Chappuis PO; Viassolo V; Ayme A; Neyroud-Caspar I; Usel M; Bouchardy C
    Cancer Med; 2017 Mar; 6(3):526-536. PubMed ID: 28211614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic contribution of clinical breast cancer subtype, age, and race among patients with breast cancer brain metastases.
    Anders CK; Deal AM; Miller CR; Khorram C; Meng H; Burrows E; Livasy C; Fritchie K; Ewend MG; Perou CM; Carey LA
    Cancer; 2011 Apr; 117(8):1602-11. PubMed ID: 21472708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognosis in different subtypes of metaplastic breast cancer: a population-based analysis.
    He X; Ji J; Dong R; Liu H; Dai X; Wang C; Esteva FJ; Yeung SJ
    Breast Cancer Res Treat; 2019 Jan; 173(2):329-341. PubMed ID: 30341462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant chemotherapy in pT1ab node-negative triple-negative breast carcinomas: Results of a national multi-institutional retrospective study.
    de Nonneville A; Gonçalves A; Zemmour C; Cohen M; Classe JM; Reyal F; Colombo PE; Jouve E; Giard S; Barranger E; Sabatier R; Bertucci F; Boher JM; Houvenaeghel G
    Eur J Cancer; 2017 Oct; 84():34-43. PubMed ID: 28780480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triple-negative breast cancer: the impact of guideline-adherent adjuvant treatment on survival--a retrospective multi-centre cohort study.
    Schwentner L; Wolters R; Koretz K; Wischnewsky MB; Kreienberg R; Rottscholl R; Wöckel A
    Breast Cancer Res Treat; 2012 Apr; 132(3):1073-80. PubMed ID: 22205141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.